Sponsor Pipeline

Geneplus-Beijing Co. Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
5
Recruiting
4
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-02 NCT03614689
Assessment of the Minimal Residual Disease in Ovarian Cancer From Circulating Tumor DNA…
overall status: Active, Not Recruiting → Unknown
Active Trials by Phase
Not specified
7
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT04353557 ctDNA Monitoring in Early Breast Cancer Breast Cancer Recruiting
NCT06876610 Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer Breast Cancer Screening Recruiting
NCT05965557 Exploration of Predictive Markers of Neoadjuvant Immunotherapy in Non-Small Cell Lung… Lung Cancer Recruiting
NCT06098560 Circulating Tumor DNA (ctDNA) as a Predictive Biomarker for Immunotherapy in Advanced or… Colorectal Cancer Recruiting
NCT07681323 Timing of ctDNA Testing in Advanced Breast Cancer Advanced Breast Cancer Recruiting
NCT06283875 The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical… Ovarian Cancer Not Yet Recruiting
NCT04405557 The PREDICT Study: Prospective Early Detection In a Population at High-risk for Common… Early Detection of Cancer Active, Not Recruiting
Disease Areas
Get alerts when Geneplus-Beijing Co. Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free